Harbour Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Harbour Investments’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.9K	Sell	61 -8	-12%	-$2.27K	﹤0.01%	3016
2026 Q1	$19.2K	Buy	69 +2	+3%	+$576	﹤0.01%	2912
2025 Q4	$20.3K	Hold	67	–	–	﹤0.01%	2411
2025 Q3	$18.8K	Hold	67	–	–	﹤0.01%	2377
2025 Q2	$16.2K	Sell	67 -3	-4%	-$709	﹤0.01%	2342
2025 Q1	$17K	Sell	70 -1	-1%	-$301	﹤0.01%	2260
2024 Q4	$23.3K	Hold	71	–	–	﹤0.01%	2054
2024 Q3	$23.8K	Hold	71	–	–	﹤0.01%	1978
2024 Q2	$19.4K	Hold	71	–	–	﹤0.01%	1966
2024 Q1	$24.6K	Sell	71 -7	-9%	-$2.3K	﹤0.01%	1856
2023 Q4	$25.2K	Buy	78 +2	+3%	+$627	﹤0.01%	1761
2023 Q3	$27.2K	Buy	76 +14	+23%	+$5.4K	﹤0.01%	1614
2023 Q2	$23.5K	Hold	62	–	–	﹤0.01%	1692
2023 Q1	$29.7K	Hold	62	–	–	﹤0.01%	1567
2022 Q4	$26.1K	Buy	62 +2	+3%	+$807	﹤0.01%	1567
2022 Q3	$30K	Hold	60	–	–	﹤0.01%	1471
2022 Q2	$30K	Buy	+60	New	+$31.2K	﹤0.01%	1471
2021 Q4	$40K	Sell	53 -61	-54%	-$45.6K	﹤0.01%	1358
2021 Q3	$85K	Sell	114 -3	-3%	-$2.25K	﹤0.01%	1469
2021 Q2	$75K	Buy	117 +38	+48%	+$23.1K	﹤0.01%	1553
2021 Q1	$45K	Buy	+79	New	+$46.8K	﹤0.01%	1753

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Harbour Investments's BIO Position: Q2 2026 in Review

Harbour Investments reduced its Bio-Rad Laboratories Class A (BIO) stake by 12% in Q2 2026, selling an estimated $2.27K and leaving 61 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

Harbour Investments first reported a position in BIO in Q1 2021 and has held it in 21 quarters since. The position peaked at $85K in Q3 2021. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Harbour Investments held 61 shares of Bio-Rad Laboratories Class A worth $17.9K as of Q2 2026.
Harbour Investments sold 8 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $2.27K.
Bio-Rad Laboratories Class A made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3016 holding.
Harbour Investments first reported a position in Bio-Rad Laboratories Class A in Q1 2021 and has held it in 21 quarters since.
Harbour Investments's Bio-Rad Laboratories Class A position peaked at $85K in Q3 2021.
400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.